ClinConnect ClinConnect Logo
Search / Trial NCT06798103

Comparing Perioperative Analgesia After Ultrasound Guided Bilateral Erector Spinae Plane Block and Thoracic Paravertebral Block in Laparoscopic Sleeve Gastrectomy Patients

Launched by AIN SHAMS UNIVERSITY · Jan 27, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Laparoscopic Sleeve Gastrectomy (Lsg) Erector Spinae Plane Block Thoracic Paravertebral Block

ClinConnect Summary

This clinical trial is studying how two different types of pain relief techniques can help patients after a laparoscopic sleeve gastrectomy, which is a type of weight-loss surgery. The researchers want to find out whether an ultrasound-guided erector spinae plane block or a thoracic paravertebral block is more effective in managing pain during the first 24 hours after the surgery. They will measure pain levels using a simple scale where patients rate their discomfort.

To participate in this study, you need to be between 21 and 60 years old and be undergoing this specific surgery. Both men and women can join, but certain conditions, like having a bleeding disorder or a history of allergies to local anesthetics, may prevent someone from participating. If you take part, you can expect to receive one of the two pain relief methods during your surgery, and the goal is to help you recover more quickly and feel more comfortable afterward. The trial is not yet recruiting participants, so there’s still time to learn more and consider if this study is right for you.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age: 21 to 60 years.
  • 2. Sex: males and females
  • 3. Patients with American Society of Anesthesiologists physical status 4.classifications II-III undergoing laparoscopic sleeve gastrectomy under general anaesthesia.
  • Exclusion Criteria:
  • 1. Patient refusing to participate in the study.
  • 2. Patients with bleeding disorders.
  • 3. A history of relevant local anaesthetic allergy.
  • 4. Patients with muscle diseases.
  • 5. Evidence of local infection at site of injection.
  • 6. Pre-existing chronic pain or cognitive dysfunction (which would impede accurate engagement with postoperative quality of recovery and analgesia assessment)

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Patients applied

0 patients applied

Trial Officials

Farouk Kamaleldin Abdelaziz, MD, Lecturer

Principal Investigator

Faculty of Medicine, Ain Shams University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported